Sulfonylurea Drugs Do Not Influence Initial Stroke Severity and In-Hospital Outcome in Stroke Patients With Diabetes

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Stroke

• Publication date

  2001-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/STR.32.9.2029PMID 11546892
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes

  2002cited by this paper
• Molecular characterization of human SUR2-containing K(ATP) channels.

  2000influential reference
• Do transient ischemic attacks have a neuroprotective effect?

  2000cited by this paper
• Hypercapnia-induced cerebral and ocular vasodilation is not altered by glibenclamide in humans.

  2000cited by this paper
• Myocardial infarction in diabetic vs non-diabetic subjects. Survival and infarct size following therapy with sulfonylureas (glibenclamide)

  2000cited by this paper
• Diabetes, coronary heart disease and sulphonylureas-not the final word.

  2000cited by this paper
• Guidelines for the management of hypertension.

  2000cited by this paper
• Relation between sulfonylurea therapy, complications, and outcome for elderly patients with acute myocardial infarction.

  1999cited by this paper
• Rapid preconditioning neuroprotection following anoxia in hippocampal slices: role of the K+ ATP channel and protein kinase C.

  1999cited by this paper
• Treatment of Ischaemic Stroke

  1999cited by this paper
• 1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. Guidelines sub-committee of the World Health Organization.

  1999cited by this paper
• Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction.

  1999cited by this paper
• Attenuated stroke severity after prodromal TIA: a role for ischemic tolerance in the brain?

  1999cited by this paper
• Clinical correlates of the initial and long-term cost of coronary bypass surgery and coronary angioplasty.

  1999cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• The Diabetes Control and Complications Trial

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

  1998cited by this paper
• Retrospective assessment of initial stroke severity with the Canadian Neurological Scale.

  1997cited by this paper
• Modulation of K+ channels by intracellular ATP in human neocortical neurons.

  1997cited by this paper
• Interaction of sulphonylurea derivatives with vascular ATP-sensitive potassium channels in humans

  1996cited by this paper
• Essential role of adenosine, adenosine A1 receptors, and ATP-sensitive K+ channels in cerebral ischemic preconditioning.

  1995cited by this paper
• Ischemic Preconditioning During Coronary Angioplast Is Prevented by Glibenclamide, a Selective ATP‐Sensitive K+ Channel Blocker

  1994cited by this paper
• Sulfonylurea binding sites in normal human brain and in Parkinson's disease, progressive supranuclear palsy and Huntington's disease.

  1994cited by this paper
• Stroke in the diabetic patient.

  1994cited by this paper
• Classification of Subtype of Acute Ischemic Stroke: Definitions for Use in a Multicenter Clinical Trial

  1993cited by this paper
• The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

  1993cited by this paper
• Stroke topography and outcome in relation to hyperglycaemia and diabetes.

  1992cited by this paper
• The Canadian Neurological Scale

  1989cited by this paper
• Interobserver agreement for the assessment of handicap in stroke patients.

  1989cited by this paper
• Interobserver agreement for the assessment of handicap in stroke patients.

  1988cited by this paper
• Prevalence and Mortality of Acute Myocardial Infarction in Patients with Diabetes

  1985influential reference
• Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall study.

  1983cited by this paper
• Increased damage after ischemic stroke in patients with hyperglycemia with or without established diabetes mellitus.

  1983cited by this paper
• Diabetes and cardiovascular disease. The Framingham study.

  1979influential reference
• A Study of the Effects of Hypoglycemic Agents on Vascular Complications in Patients with Adult-onset Diabetes: VI. Supplementary Report on Nonfatal Events in Patients Treated with Tolbutamide

  1976cited by this paper
• A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results.

  1970cited by this paper

• Unraveling the Genetic Links: The Impacts of Antidiabetic Drugs on Stroke Risk

  2025cites this paper
• Targeting the TRPM4 Channel for Neurologic Diseases: Opportunity and Challenge

  2025cites this paper
• Associations of diabetes status and glucose measures with outcomes after endovascular therapy in patients with acute ischemic stroke: an analysis of the nationwide TREAT-AIS registry

  2024cites this paper
• The Impact of Pre-Stroke Metformin Use on Clinical Outcomes after Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.

  2024cites this paper
• TRPM4 Blocking Antibody Protects Cerebral Vasculature in Delayed Stroke Reperfusion

  2023cites this paper
• Discovery of Potential Anti-Ischemic Stroke Agents Through Inhibiting Sulfonylurea Receptor 1 (SUR1): A Pharmacophore-based Screening, Docking, and Molecular Dynamic Simulation

  2021cites this paper
• TRPM4-specific blocking antibody attenuates reperfusion injury in a rat model of stroke

  2019cites this paper
• Association of Antihyperglycemic Therapy with Risk of Atrial Fibrillation and Stroke in Diabetic Patients

  2019cites this paper
• Profile of intravenous glyburide for the prevention of cerebral edema following large hemispheric infarction: evidence to date

  2018cites this paper
• Non-Invasive Multimodality Imaging Directly Shows TRPM4 Inhibition Ameliorates Stroke Reperfusion Injury

  2018cites this paper
• The role of KATP channels in cerebral ischemic stroke and diabetes

  2018cites this paper
• Impact of glucose-lowering therapies on risk of stroke in type 2 diabetes.

  2017cites this paper
• Neurological outcomes of antidiabetic therapy: What the neurologist should know.

  2017cites this paper
• Antidiabetic drugs and stroke risk. Current evidence.

  2017cites this paper
• Impact of Hemorheology Assessed by the Microchannel Method on Pulsatility Index of the Common Carotid Artery in Patients With Type 2 Diabetes Mellitus

  2017cites this paper
• Is There Enhanced Risk of Cerebral Ischemic Stroke by Sulfonylureas in Type 2 Diabetes?

  2016cites this paper
• Opposite roles of bradykinin B1 and B2 receptors during cerebral ischaemia–reperfusion injury in experimental diabetic rats

  2016cites this paper
• Impact of Metformin on the Severity and Outcomes of Acute Ischemic Stroke in Patients with Type 2 Diabetes Mellitus.

  2016cites this paper
• Addressing Limitations in Observational Studies of the Association Between Glucose-Lowering Medications and All-Cause Mortality: A Review

  2015cites this paper
• Glibenclamide for the Treatment of Ischemic and Hemorrhagic Stroke

  2015cites this paper
• Poor outcome of experimental ischemic stroke in type 2 diabetic rats: impaired circulating endothelial progenitor cells mobilization.

  2015cites this paper
• Prior treatment with dipeptidyl peptidase 4 inhibitors is associated with better functional outcome and lower in-hospital mortality in patients with type 2 diabetes mellitus admitted with acute ischaemic stroke

  2015cites this paper
• Antidiabetic treatment, stroke severity and outcome.

  2014cites this paper
• Observational studies of the association between glucose-lowering medications and cardiovascular outcomes: addressing methodological limitations

  2014cites this paper
• Glibenclamide in Cerebral Ischemia and Stroke

  2014cites this paper
• Adipositas und deren Bedeutung für ausgewählte neurologische Erkrankungen

  2014cites this paper
• Ischemic Stroke Potential Impact of Sulfonylureas in the Outcome of Type 2 Diabetic Patients With

  2013cites this paper
• Does inhibiting Sur1 complement rt‐PA in cerebral ischemia?

  2012cites this paper
• Type of preadmission antidiabetic treatment and outcome among patients with ischemic stroke: a nationwide follow-up study.

  2012cites this paper
• Sulfonylurea Use Before Stroke Does Not Influence Outcome

  2011cites this paper
• Diabetes and the brain

  2010cites this paper
• Stroke and Diabetes Mellitus

  2009cites this paper
• Early changes in physiological variables after stroke

  2008cites this paper
• Sulfonylureas Improve Outcome in Patients With Type 2 Diabetes and Acute Ischemic Stroke

  2007cites this paper
• Effect of adenosine triphosphate-sensitive potassium channel inhibitors on coronary metabolic vasodilation.

  2007cites this paper
• Potential impact of sulfonylureas in the outcome of type 2 diabetic patients with ischemic stroke.

  2007cites this paper
• Lacunar Infarction in Type 2 Diabetes Is Associated with an Elevated Intracranial Arterial Pulsatility Index

  2007cites this paper
• Sulphonylureas and cardiovascular risk: facts and controversies

  2006cites this paper
• Review: Sulphonylureas and cardiovascular risk: facts and controversies

  2006cites this paper
• Diabetes mellitus and stroke

  2005cites this paper
• Stroke in patients with diabetes mellitus

  2004cites this paper
• Management of diabetes and hyperglycemia in hospitals.

  2004cites this paper
• Canal cationique non selectif dans des cellules neuronales et procedes de traitement d'oedeme cerebral

  2003cites this paper
• RISK FOR STROKE IN DIABETIC PATIENT

  year unknowncites this paper